Navigation Links
CDC Foundation Launches Viral Hepatitis Action Coalition
Date:1/11/2010

Coalition will respond to the Institute of Medicine Report on Viral Hepatitis and support CDC research and programs

ATLANTA, Jan. 11 /PRNewswire-USNewswire/ -- In anticipation of the release of the Institute of Medicine (IOM) report on viral hepatitis, the CDC Foundation (the independent nonprofit partner of the Centers for Disease Control and Prevention), in partnership with CDC's Division of Viral Hepatitis, recently launched the Viral Hepatitis Action Coalition. The Coalition is comprised of private-sector organizations committed to supporting high priority research, education and program evaluation projects initiated by CDC's Division of Viral Hepatitis. In addition to providing funding for specific projects, Coalition members also will support CDC by sharing research data, connecting CDC to appropriate stakeholders and networks, and providing feedback on the information and tools needed in the field to respond to the recommendations outlined in the IOM report.

Founding Viral Hepatitis Action Coalition members include: Gilead Sciences, Inc.; Merck & Co., Inc.; OraSure Technologies; and Vertex Pharmaceuticals. In addition to supporting the overall Coalition, members will have the opportunity to fund and partner with CDC on CDC-led research and education projects as priorities are identified. Two initial priority projects include a study called Birth-cohort Evaluation to Advance Screening and Testing for Hepatitis C (BEST-C) and a national hepatitis education campaign. For each project, Coalition members will reach out to other critical partners in the hepatitis community as appropriate, including partners from academia, patient advocacy and other hepatitis-related groups. Coalition members are committed to engaging the entire hepatitis community in efforts to improve screening and treatment of viral hepatitis.

The Viral Hepatitis Action Coalition is seeking additional membership, and those interested in membership should contact Leah-Lane Lowe at 404.653.0790 or llowe@cdcfoundation.org. To learn more about CDC's Division of Viral Hepatitis, please visit www.cdc.gov/hepatitis.

Established by Congress, the CDC Foundation is the independent, nonprofit partner of the Centers for Disease Control and Prevention. The CDC Foundation helps CDC do more, faster by forging effective partnerships between CDC and individuals, corporations and foundations to fight threats to health and safety. To learn more, please visit www.cdcfoundation.org.

SOURCE CDC Foundation

RELATED LINKS
http://www.cdcfoundation.org

'/>"/>

SOURCE CDC Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kevin McHale Instrumental in Forming the Help Me Hear Foundation
2. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
3. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
4. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
5. The Oral Cancer Foundation Urges HPV Vaccination for Males
6. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
7. Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium
8. Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
9. Five Clinical Studies to Receive $2.5 Million Under Foundations 2007 Clinical Discovery Program
10. Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1
11. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... Conn., May 4, 2016  Compass Diversified Holdings (NYSE: ... "Company"), an owner of leading middle market businesses, announced ... ended March 31, 2016. First Quarter 2016 ... and Reinvestment ("CAD" or "Cash Flow") of $13.6 million ... net loss of $15.0 million for the first quarter ...
(Date:5/4/2016)... May 4, 2016 Yissum ... announced today that it had signed an exclusive ... , developer of novel protein degradation and immunomodulatory drugs ... commercialization of drug candidates representing first-in-class therapy for hematologic ... not disclosed. The novel technology was developed ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Myeloid Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Myeloid Leukemia epidemiology, Acute Myeloid ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... Chronic stress can have a silent, yet ... weaken the immune system and increase inflammation, both of which raise the risk of ... congenital heart disease program at Harvard-affiliated Massachusetts General Hospital. Chronic stress also can lead ...
(Date:5/5/2016)... Texas (PRWEB) , ... May 05, 2016 , ... ... relationship-marketing firm, honored finalists and winners Tuesday evening, May 3, at the 2016 ... Texas. , Scott Pettigrew, Vice President and Chief Security Officer of HMS, ...
(Date:5/5/2016)... ... 2016 , ... If you don’t mind a bit of prickly therapy to ... to consider a treatment that some have called the next great tool in dermatology ... also known as skin needling, is a procedure using a device covered with tiny, ...
(Date:5/5/2016)... ... 05, 2016 , ... Pigment Laser Tattoo Removal Center is proud to be ... PiQo4™ laser, the first 4-wavelenth picosecond laser to receive FDA Clearance. This new ... on the market. Jeremy Miller, Tattoo Artist and former reality show contestant on ...
(Date:5/5/2016)... ... May 05, 2016 , ... Liposuction specialist Marcia V. Byrd, MD spoke ... Missouri at the Marriot St. Louis Airport Hotel. This year’s conference was titled “Living ... conference about her unique specialization in treating Lipedema. Dr. Byrd is considered one of ...
Breaking Medicine News(10 mins):